Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
Crossref DOI link: https://doi.org/10.1038/srep26611
Published Online: 2016-05-24
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Yong
Tu, Mei-Juan
Wang, Wei-Peng
Qiu, Jing-Xin
Yu, Ai-Xi
Yu, Ai-Ming
Text and Data Mining valid from 2016-05-24
Version of Record valid from 2016-05-24
Article History
Received: 9 March 2016
Accepted: 5 May 2016
First Online: 24 May 2016
Competing interests
: The authors declare no competing financial interests.